OTUB1 is a Lys48-specific deubiquitinating enzyme that forms a complex in vivo with E2 ubiquitin (Ub)-conjugating enzymes including UBC13 and UBCH5. OTUB1 binds E2~Ub thioester intermediates and prevents ubiquitin transfer, thereby noncatalytically inhibiting accumulation of polyubiquitin. We report here that a second role of OTUB1-E2 interactions is to stimulate OTUB1 cleavage of Lys48 polyubiquitin. This stimulation is regulated by the ratio of charged to uncharged E2 and by the concentration of Lys48-linked polyubiquitin and free ubiquitin. Structural and biochemical studies of human and worm OTUB1 and UBCH5B show that the E2 enzyme stimulates binding of the Lys48 polyubiquitin substrate by stabilizing folding of the OTUB1 N-terminal ubiquitin-binding helix. Our results suggest that OTUB1-E2 complexes in the cell are poised to regulate polyubiquitin chain elongation or degradation in response to changing levels of E2 charging and available free ubiquitin. npg
Ubiquitination has a pivotal role in regulating a broad range of physio logical processes including proteasomal degradation, transcription, membrane trafficking and the DNAdamage response 1 . Substrates are modified through the E1E2E3 enzyme cascade with a single ubiq uitin or with different types of polyubiquitin chains distinguished by the particular ubiquitin lysine through which one ubiquitin is joined to the next 1 . Deubiquitinating enzymes (DUBs) remove ubiq uitin from substrates as well as disassemble polyubiquitin chains 2, 3 . The balance between the opposing activities of ubiquitinating and deubiquitinating enzymes thus has a central role in modulating ubiquitin signaling by determining the levels and distribution of ubiquitination in the cell.
OTUB1 is a DUB that belongs to the OTU family of cysteine pro teases 4 and is highly specific for cleaving Lys48linked polyubiquitin chains 5 . OTUB1 has been implicated in regulating diverse processes including Tcell anergy 6 , virustriggered interferon1 induction 7 and stabilization of p53 (ref. 8) , estrogen receptor α (ref. 9 ) and cIAP 9 . Although the catalytic residues of OTUB1 are conserved across spe cies 4 , this enzyme was unexpectedly found to have a noncatalytic role in inhibiting accumulation of Lys63linked polyubiquitin in the response to DNA doublestrand breaks 10 . OTUB1 inhibits Lys63 polyubiquitin chain synthesis by the E2 UBC13 (UBE2N), in a man ner that does not require OTUB1 DUB activity but that depends on ~40 residues N terminal to the OTUB1 catalytic domain 10 . Interestingly, OTUB1 also inhibits other E2 enzymes including UBCH5A, UBH5B and UBCH5C (UBE2D1-UBE2D 3) and UBCH6 (UBE2E1) 10 and has been found in complex with these E2 enzymes in cells 10, 11 , although the biological impact of these observations is not yet known.
Structural studies of UBC13 (ref. 12 ) and UBCH5B 13 demon strated that OTUB1 binds directly to the E2~Ub thioester and holds the donor ubiquitin in its proximal ubiquitinbinding site, which includes the OTUB1 Nterminal residues shown to be critical for inhibition 10 . OTUB1 binding to the charged E2~Ub is allosterically regulated by an additional free ubiquitin monomer that binds the OTUB1 distal ubiquitinbinding site, thus triggering conformational changes that favor binding of the UBC13~Ub donor ubiquitin in the OTUB1 proximal site 12 . These include a conformational change in the globular OTU domain and the folding of ~21 Nterminal resi dues to form a ubiquitinbinding helix 12 . The allosteric communica tion between proximal and distal ubiquitinbinding sites 5 thus helps to drive formation of a complex between OTUB1 and charged E2 enzymes. The relative configuration of proximal and distal ubiquitins mimics Lys48 diubiquitin, thus indicating that OTUB1 specificity for Lys48 isopeptide linkages as well as the allosteric communication between proximal and distal sites 5 has been adapted for noncatalytic inhibition of E2 enzymes. The requirement for the binding of a free ubiquitin monomer to OTUB1 raised the interesting possibility that changes in cellular ubiquitin concentrations might regulate the ability of OTUB1 to inhibit E2 enzymes.
The formation of the repressive complex by OTUB1 binding to charged E2~Ub and free ubiquitin presumably interferes with OTUB1 DUB activity because the occupation of both proximal and distal ubiquitinbinding sites of OTUB1 precludes binding of a Lys48 poly ubiquitin substrate. OTUB1 can also bind uncharged E2 enzymes 10, 12 , yet this should not prevent binding of Lys48 polyubiquitin substrate. We set out to investigate, on the basis of this observation, whether 1 0 3 4 VOLUME 20 NUMBER 9 SEPTEMBER 2013 nAture structurAl & moleculAr biology A r t i c l e s E2 enzymes might influence OTUB1 isopeptidase activity. Here we report a new role for OTUB1E2 interactions in stimulating the Lys48 DUB activity of OTUB1. We find that OTUB1 DUB activity is strongly stimulated by selected E2 enzymes and that this stimulation is dependent on whether the E2 enzymes are charged with ubiquitin as well as on the concentration of free ubiquitin. The relative proportion of charged and uncharged E2s and the concentration of both Lys48 chains and free ubiquitin determine the balance between OTUB1-E2 complexes (which actively cleave Lys48 polyubiquitin chains) and inhibited OTUB1-Ub-E2~Ub complexes (which block both OTUB1 DUB activity and E2 ubiquitinconjugating activity). Our results show that a portion of the E2 partners of OTUB1 are not charged in cells, thus indicating that many of the OTUB1-E2 complexes in vivo are active as DUBs. OTUB1-E2 complexes are thus poised to serve a dual role in regulating levels of ubiquitin conjugation in response to fluctuations in E2 charging and available free ubiquitin.
RESULTS

E2 enzymes stimulate OTUB1 Lys48 deubiquitinating activity
To test the effect that E2 enzymes might have on OTUB1 activity, we measured the ability of OTUB1 to cleave Lys48linked diubiquitin in the presence of 11 human E2 enzymes. We found that, unexpectedly, five of the E2s tested (UBCH5A-UBCH5C, UBE2W and UBCH6) strongly stimulated Lys48 diubiquitin cleavage by OTUB1 in a fluores cence resonance energy transfer (FRET)based assay ( Fig. 1a) . With the exception of UBE2W, these enzymes had previously been shown to interact with OTUB1 (refs. 10, 11) . Surprisingly, UBC13, which is inhibited by OTUB1, did not stimulate OTUB1 as strongly as did the other activating E2s. We assayed OTUB1 stimulation as a function of UBCH5B concentration and found that halfmaximal stimulation of OTUB1 cleavage activity occurred at 0.5 µM UBCH5B ( Fig. 1b and Supplementary Table 1 ). To confirm that the observed stimula tion was not assay dependent, we used a gelbased assay to verify that UBCH5B stimulates OTUB1 cleavage of native Lys48linked diubiquitin ( Fig. 1c and Supplementary Fig. 1 ). In the absence of UBCH5B, OTUB1 consumed all of the diubiquitin substrate in 60 min, whereas OTUB1 processed the same amount of diubiquitin in 3 min when UBCH5B was present. We observed no difference in stimulation in cleavage of di, tri and tetraubiquitin substrates ( Supplementary  Fig. 2) , results indicating that E2 stimulation of OTUB1 DUB activity is independent of polyubiquitin chain length.
To gain insight into how OTUB1 isopeptidase activity is stimulated, we determined steadystate kinetic parameters for Lys48 diubiquitin cleavage by OTUB1 in the presence and absence of UBCH5B ( Fig. 1d and Supplementary Table 2 ). UBCH5B reduced the K m of OTUB1 for Lys48 diubiquitin to one thirtyfifth of its value in the absence of UBCH5B (from 120 µM to 3.4 µM) but had no effect on k cat (0.035 s −1 and 0.036 s −1 in the presence and absence of UBCH5B, respectively). These results indicate that UBCH5B stimulates OTUB1 by increasing its affinity for the Lys48 diubiquitin substrate.
E2 interactions mediate OTUB1 stimulation and inhibition
Because the ubiquitin monomers in inhibited OTUB1-Ub-E2~Ub complexes 12, 13 apparently mimic the binding of Lys48 diubiquitin, we first asked whether the same residues in OTUB1 that are involved in inhibiting E2 enzymes are also required for OTUB1 to be stimulated by E2s. An OTUB1 T134R substitution in the catalytic OTU domain that disrupts binding to UBCH5B was previously shown to reduce OTUB1 inhibition of UBCH5B ubiquitinconjugating activity 13 . We assayed the ability of OTUB1 T134R to be stimulated by UBCH5B and found that this mutant was insensitive to UBCH5B, a result sug gesting that the same OTUB1E2 interface is needed for both stimu lation and inhibition ( Fig. 2a) . Because the Nterminal residues of OTUB1 that precede the OTU domain form a proximal ubiquitin binding helix that has an essential role in E2 inhibition, we asked whether E2 stimulation of OTUB1 activity similarly requires the OTUB1 N terminus. Deletion of the 15 Nterminal residues of OTUB1 did not affect its ability to be stimulated by UBCH5B, whereas deletion 
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A r t i c l e s of the first 30 Nterminal residues completely disrupted stimulation ( Fig. 2b) . These results are consistent with a role for the OTUB1 Nterminal helix similar to that in the OTUB1-Ub-UBC13~Ub inhibited complex, in which the first 23 residues are disordered, and residues 24-44 form a ubiquitinbinding helix 12 .
The importance of the OTUB1 Nterminal helix to its ability to be stimulated by UBCH5B, together with the role of these Nterminal residues in forming the proximal ubiquitinbinding site of OTUB1 (refs. 5,12,13) , suggested that UBCH5B may increase OTUB1 affinity for Lys48 diubiquitin through the proximal ubiquitinbinding site. We hypothesized, on the basis of this interpretation, that UBCH5B would not stimulate OTUB1 cleavage of ubiquitinaminomethyl coumarin (ubiquitinAMC), a substrate that binds the distal ubiqui tinbinding site of OTUB1 but contains an amidelinked fluorophore in place of a proximal ubiquitin. Indeed, UBCH5B did not stimulate ubiquitinAMC cleavage by OTUB1 ( Fig. 2c) , consistent with the idea that UCH5B increases the affinity of OTUB1 for the proximal ubiquitin in Lys48 diubiquitin but does not affect substrate binding to the distal ubiquitinbinding site.
Structural basis for stabilization of the OTUB1 N terminus by E2
Our results suggested that UBCH5B stimulates binding of the Lys48 linked proximal ubiquitin to the OTUB1 Nterminal ubiquitin binding helix. These residues, which are N terminal to the OTU catalytic domain, are disordered in the apoenzyme 12, 14 but form an αhelix when OTUB1 is bound to both distal ubiquitin and charged UBC13~Ub 12 or UBCH5B~Ub 13 . Given the absence of a structure of OTUB1 bound to Lys48 diubiquitin and E2, we took advantage of the observation that the two ubiquitins bound to the proximal and distal sites of OTUB1 mimic the binding of Lys48 diubiquitin 12, 13 and examined the structural effect of E2 binding on the Nterminal ubiquitinbinding helix of OTUB1. The aforementioned reported structures, however, do not show direct contacts between the E2 and the OTUB1 Nterminal arm, possibly owing to limits in data resolu tion and order 12, 13 . In addition, the structure of the UBCH5B repres sion complex contains UBCH5B fused directly to a truncated OTUB1 Nterminal helix 13 , and thus it does not address how an untethered OTUB1 N terminus might contact UBCH5B. We therefore deter mined a 1.9Åresolution crystal structure of UBCH5B C85S~U b bound to OTUB1 containing ubiquitin aldehyde (Ubal) bound to its distal site (data collection and refinement statistics shown in Table 1 ). The structure contains a hybrid OTUB1 containing the Nterminal 45 residues of human OTUB1 and the OTU domain of worm OTUB1, which was used in previous structural studies of the OTUB1-Ubal-UBC13~Ub repression complex 12 . The human UBCH5B protein con tained an active site C85S mutation, which was used to generate an oxyester linkage, rather than the more labile thioester, between the E2 and the ubiquitin C terminus. In the present structure, the Nterminal 22 residues of OTUB1 are disordered, whereas residues 23-44 (hOTUB1 numbering) form a wellordered αhelix, consistent with the effect of Nterminal deletions on stimulation by UBCH5B ( Fig. 3a and Supplementary Fig. 3) . A Lys48 isopeptide linkage between the two ubiquitins can be readily modeled through minor adjustments of the proximal Lys48 side chain and the distal ubiquitin aldehyde C terminus, which is covalently linked to the OTUB1 active site cysteine by a thiohemiacetal bond ( Supplementary Fig. 4 ). This structure was The structure of the OTUB1-Ubal-UBCH5B~Ub complex reveals a network of direct and watermediated contacts between UBCH5B and the Nterminal helix of OTUB1 that could stabilize folding of the OTUB1 N terminus. OTUB1 residue Glu28 is sand wiched between UBCH5B residues Lys66 and Arg90, and OTUB1 Asp35 hydrogen bonds with UBCH5B Lys63 while OTUB1 Leu24 forms hydrophobic interactions with UBCH5B Leu 119 ( Fig. 3a) . In addition, there are extensive contacts between the Cterminal tail of the proxi mal ubiquitin and the OTUB1 Nterminal helix ( Fig. 3a) that were not seen in previous structures 12, 13 . To test whether the observed contacts between the Nterminal helix of OTUB1 and UBCH5B are also important for stimulating OTUB1 cleavage of a Lys48 diubiquitin substrate, we introduced mutations designed to disrupt interactions between UBCH5B and the OTUB1 N terminus in the inhibited com plex and then tested whether those contacts were important to the ability of UBCH5B to stimulate OTUB1 cleavage of Lys48 diubiquitin. The OTUB1 double E28A D35A substitution, which affects OTUB1 contacts with UBCH5B, greatly decreased the ability of UBCH5B to stimulate OTUB1 DUB activity without affecting OTUB1 activity in the absence of UBCH5B (Fig. 3b) . Similarly, UBCH5B mutations R90A or K66A, which disrupt interactions with Glu28 of OTUB1 ( Fig. 3a) Figure 1b to determine IC 50 . Curves fit to the data are shown for UBCH5B (red) and UBCH5B~Ub (blue).
A r t i c l e s abolished its ability to stimulate OTUB1 (Fig. 3c) . Taken together, our results indicate that UBCH5B stimulates OTUB1 cleavage of Lys48 diubiquitin by buttressing the Nterminal helix of OTUB1, thereby stabilizing the proximal ubiquitinbinding site and raising the affinity of OTUB1 for Lys48 diubiquitin.
Free ubiquitin controls the effect of E2~Ub on OTUB1 activity
Our structural and biochemical studies showed how E2 enzymes stim ulate the DUB activity of OTUB1. However, in at least some cases, E2 enzymes in the cell are mostly charged with ubiquitin 15 , and there is also free, unconjugated ubiquitin 16 . Given the overlapping mecha nisms of noncatalytic E2 inhibition and OTUB1 activation, we asked whether OTUB1 can also be stimulated by charged UBCH5B~Ub and whether the presence of free ubiquitin affects OTUB1 deubiquitinat ing activity. Model building based on the present work and on the structure of charged UBCH5A~Ub bound to RNF4 (ref. 17 ) dem onstrates that OTUB1 in complex with Lys48 diubiquitin could bind charged UBCH5B~Ub without clashes between the additional ubiq uitin and the diubiquitin occupying the OTUB1 proximal and distal sites (Fig. 4a) . Although the thioesterlinked ubiquitin is likely to be mobile 18 , the model does not substantially restrict alternate confor mations. We assayed the ability of UBCH5B~Ub to stimulate OTUB1 ( Fig. 4b) and found that both charged and uncharged UBCH5B stimulate OTUB1 to a similar degree. However, assays of OTUB1 stimulation by UBCH5B or UBCH5B~Ub over a range of ubiquitin concentrations ( Fig. 4c and Supplementary Table 3 ) showed that stimulation by UBCH5B is relatively insensitive to free ubiquitin but that stimulation by UBCH5B~Ub decreases as a function of increasing concentration of free ubiquitin, dropping to low levels at freeubiqui tin concentrations below ~1 µM. The complete repression of OTUB1 activity at >10 µM free ubiquitin is presumably due to formation of the inhibited OTUB1-Ub-UBCH5B~Ub complex (Fig. 3a) , in which free ubiquitin binds the OTUB1 distal ubiquitinbinding site while the ubiquitin conjugated to UBCH5B binds the OTUB1 proximal site, thus precluding binding of the Lys48 diubiquitin substrate. These results indicate that although charged E2~Ub conjugates can also stimulate OTUB1 DUB activity, this stimulation would be substantial only under conditions in which local freeubiquitin concentrations drop below ~0.6 µM. Because estimates of cellular freeubiquitin concentrations range from 4 to 20 µM, this would suggest that E2~Ub conjugates would repress OTUB1 activity unless cellular stresses were to markedly reduce the availability of free ubiquitin.
E2 partners exist in charged and uncharged states in cells
Because only uncharged E2 stimulates OTUB1 DUB activity, whereas charged E2~Ub represses OTUB1 under normal cellular concentra tions of free ubiquitin, the relative proportion of charged versus uncharged E2s must be critical determinants of whether OTUB1-E2 complexes function as active DUBs in the cell. We therefore examined the ratio of charged and uncharged E2 partners of OTUB1 in the cell. Of the E2 enzymes that stimulate OTUB1 (Fig. 1a) , UBCH5C (UBE2D3) and UBC13 (UBE2N) have been shown to be the most abundant and are in molar excess over OTUB1 (ref. 19 ). We examined the ratio of charged to uncharged E2 in U2OS and HeLa cells, which were used to study noncatalytic inhibition by OTUB1 in the DNA damage response 10, 13 . We prepared cell extracts under conditions that preserve the thioester linkage 15 and probed them with antibodies against the three UBCH5 isoforms or UBC13. We unexpectedly found different E2 charging ratios for UBCH5 and UBC13 ( Fig. 5a and Supplementary Fig. 5 ). UBC13 was completely charged in HeLa cells and partially charged in U2OS cells (Fig. 5a) , whereas the major ity of UBCH5 isoforms were uncharged in both cell lines (Fig. 5a) .
Although the reasons for the differences among different cell lines and E2 enzymes are not yet known, these results indicate that a substantial proportion of the E2 enzyme partners of OTUB1 are uncharged in cultured cells. Taken together, our results suggest that OTUB1 should be stimulated by uncharged UBCH5 in cells and that variations in the ratio of E2 to E2~Ub could be involved in regulating OTUB1 isopeptidase activity.
DISCUSSION
Together with previous studies 10, 12, 13 , our results demonstrate that OTUB1-E2 complexes can serve dual functions in regulating both ubiquitin conjugation and deconjugation. The finding that OTUB1 noncatalytically represses E2 enzymes 10 left open the question of how binding to E2 enzymes affected OTUB1 deubiquitinating activity. We have shown here that a subset of E2 enzymes markedly stimu late OTUB1 cleavage of Lys48linked polyubiquitin (Fig. 1a) and that the same set of OTUB1E2 interactions are required for both OTUB1 noncatalytic inhibition of E2 enzymes and E2 stimulation of OTUB1 (refs. 12,13). E2 binding increases OTUB1 affinity for Lys48 diubiquitin by stabilizing the OTUB1 N terminus (Fig. 3a) , which is disordered in the absence of substrate 12, 14 and must fold into an αhelix to form part of the proximal ubiquitinbinding site of OTUB1 (refs. 12,13) . OTUB1 thus belongs to the expanding group of deubiquitinating enzymes that depend upon interactions with effec tor proteins that stimulate and regulate their activity 20 . Indeed, the inhibitory complex formed by OTUB1 with charged E2~Ub thioester and free ubiquitin also inhibits OTUB1 DUB activity, thus raising the possibility that inhibition of OTUB1 could be an equally important function of the OTUB1-Ub-E2~Ub inhibitory complex. OTUB1 has several key features that enable it to form different complexes with E2 enzymes, Lys48 polyubiquitin and free ubiquitin. OTUB1 contains two distinct sites, proximal and distal (Fig. 3a) , to which ubiquitin monomers can bind cooperatively 5 . In addition, the OTUB1 catalytic domain binds a subset of E2 enzymes 10 npg A r t i c l e s the Nterminal OTUB1 ubiquitinbinding helix, which is part of the proximal site, forms additional contacts with the E2 (Fig. 3a) . Because the N terminus is disordered in the absence of bound ubiquitin 12, 14 , the contacts with E2 help to stabilize this helix. The cooperativity between the two ubiquitinbinding sites in OTUB1 drives preferential binding of OTUB1 to charged E2~Ub, because the Ub conjugated to the E2 binds the proximal site of OTUB1 when a free ubiquitin monomer occupies the distal site (Fig. 3a) . The structural and ener getic coupling between these different binding interactions thus drives formation of the different OTUB1-E2-ubiquitin complexes.
Our results are consistent with a model in which OTUB1-E2 com plexes can exist in three states (Fig. 5b) , each with a different conse quence for OTUB1 DUB activity. OTUB1 bound to an uncharged E2 actively cleaves Lys48 polyubiquitin, with the E2 lowering the K m for the Lys48 polyubiquitin substrate through interactions between the OTUB1 N terminus and the E2 (Fig. 3a) . A charged E2~Ub conju gate, however, will bind OTUB1 with the conjugated donor ubiquitin bound in the OTUB1 proximal site, while free ubiquitin binds the OTUB1 distal site and allosterically stimulates binding of OTUB1 to the E2~Ub conjugate. This configuration ( Fig. 3a and refs. 12,13 ) precludes Lys48 diubiquitin substrate binding, thereby shutting down E2 stimulation and inhibiting diubiquitin cleavage as well as inhibiting the E2. Only if freeubiquitin concentrations were to drop below 1 µM would the inhibitory complex no longer be favored (Fig. 5b) , thus allowing the donor ubiquitin to be released from the proximal site and Lys48 diubiquitin to bind instead (Fig. 5b) . The different OTUB1-E2 complexes are in equilibrium with free OTUB1, which has lower iso peptidase activity, and free E2 and E2~Ub, which are able to conjugate ubiquitin in concert with E1 and E3 enzymes. In vivo, the relative balance between different OTUB1 and E2 states will be determined by the proportion of free E2 to E2~Ub thioester and the concentra tions of free ubiquitin and Lys48 polyubiquitin substrate. Although free ubiquitin can directly regulate OTUB1 by promoting binding to E2~Ub conjugates, it appears more likely that transient reductions in free ubiquitin would affect OTUB1 activity by lowering the proportion of E2 enzymes that are charged, given the very low freeubiquitin con centrations at which repression by E2~Ub thioester is released. The availability of Lys48 polyubiquitin substrate could have an additional role in favoring active over repressed OTUB1. Because the proximal ubiquitin in an unanchored polyubiquitin chain could bind OTUB1 in the same manner as does free monoubiquitin, it is also possible that free chains of other linkage types could also modulate OTUB1 activity by driving the formation of complexes with charged E2s.
Whether OTUB1-E2 complexes act as DUBs or inhibitors of poly ubiquitination would thus depend upon the relative proportion of charged versus uncharged E2 enzymes and the local concentration of free ubiquitin and Lys48 polyubiquitin (Fig. 5b) . We examined the E2/E2~Ub ratio for two different E2 partners of OTUB1 and found that the majority of UBCH5 isoforms are uncharged in two different cell lines, whereas UBC13 is largely in its ubiquitincharged form in HeLa cells and ~50% charged in U2OS cells (Fig. 5a) . Although the reason for the observed differences between E2s and between cell lines awaits further study, these results demonstrate that relative charging of E2 enzymes varies to a surprising extent between different E2s and in different cell lines. Notably, the substantial proportion of the E2 partners of OTUB1 that are uncharged is consistent with a role for E2 stimulation of OTUB1 in the cell. Because steadystate levels of E2 charging were investigated here in the absence of stress or DNA damage, these findings leave open the interesting question of whether the cellular ratio of charged to uncharged E2 changes under different cellular conditions and thereby regulates OTUB1 activity.
Another important determinant of OTUB1 activity must be the relative intracellular concentration of OTUB1 and its E2 partners, which, along with the E2/E2~Ub ratio, will also govern the relative proportion of OTUB1 that is bound to an E2. A study that quanti tated the absolute amounts of proteins in mouse embryonic fibroblasts (MEFs) 19 found OTUB1 to be the most abundant DUB (out of ~90), at 1.5 × 10 6 copies per cell, which corresponds to a concentration of 1.1 µM (assuming a 2,000 µm 3 cell volume). The most abundant E2 partners of OTUB1 were UBCH5C (1.7 µM) and UBC13 (1.3 µM) . Together, these E2 enzymes are in 2.7fold molar excess over OTUB1 and have a combined concentration of nearly 10 times the half maximal effective concentration (EC 50 ) for UBCH5 stimulation of OTUB1 DUB activity (Fig. 1b) . Other E2 partners of OTUB1 such as UBCH6 were present in MEFs at either far lower concen trations or were not detected 19 . Taken together with our results on E2 charging (Fig. 5a) , these quantities suggest that the majority of OTUB1-E2 complexes should serve as active DUBs in U2OS cells, in which a very low proportion of either UBCH5 or UBC13 is charged. A mixture of active and repressed OTUB1-E2 complexes would be more likely in HeLa cells, in which UBC13 is fully charged, whereas UBCH5 isoforms are largely uncharged. Differences in localiza tion of either OTUB1 or E2 enzymes, or in the ratio of charged to uncharged E2 could further govern the activity of OTUB1 in different subcellular compartments.
OTUB1-E2 complexes are poised to serve as molecular sensors that can toggle between cleaving Lys48 polyubiquitin to release free ubiquitin monomers and inhibiting ubiquitination by a subset of polyubiquitinating (UBCH5A-UBCH5C and UBC13) and mono ubiquitinating (UBE2W and UBCH6) E2 enzymes. The availability of adequate free ubiquitin in the cell is critical for proper functioning of a host of processes and appears to be tightly regulated 21 . During proteotoxic stress, when the pool of free ubiquitin decreases, the cell increases the freeubiquitin concentration and prioritizes the use of free ubiquitin in specific ubiquitination pathways 16, 22 . Depletion of cytoplasmic free ubiquitin, for example, leads to rapid cleavage of monoubiquitin from histone H2A and export of ubiquitin from the nucleus 22 , whereas heat shock in yeast leads to cleavage of unanchored ubiquitin chains and release of free ubiquitin monomers 23 . To what degree the pool of free ubiquitin and the ratio of charged to uncharged E2 may fluctuate after DNA damage, in which OTUB1 has been shown to have a role 10 , is unknown. We speculate that the initial response to stresses such as DNA damage, which involves rapid accumulation of ubiquitinated species in the nucleus as well as in the cytoplasm, may transiently reduce the ratio of charged to uncharged E2 enzymes as well as the available pool of free ubiquitin. This would alter the balance of OTUB1-E2 states in favor of OTUB1 bound to uncharged E2, a com plex that actively degrade Lys48 polyubiquitin (Fig. 5b) . The reduction in the proportion of charged E2s would also free some E2 enzymes to be available to ubiquitinate substrates. Recovery of cellular free ubiq uitin and E2 charging, either through the activity of OTUB1 or other DUBs, would again favor formation of the repressed complex and con sequent inhibition of both OTUB1 and E2 activity. Accumulation of Lys48 polyubiquitin could further tip the balance in favor of the active DUB complex by competing with charged E2~Ub thioester for binding to the ubiquitinbinding sites of OTUB1 (Fig. 5b) . The energetic cou pling of complex formation between OTUB1, Lys48 polyubiquitin and E2 could also account for the enhanced ability of the OTUB1 catalytic mutant to suppress ubiquitination at DNAdamage sites 10 . By binding but not cleaving Lys48 chains, the OTUB1 C91S mutant could seques ter uncharged E2 enzymes and globally reduce ubiquitination even in the absence of DNA damage, as has been reported 13 . Our model thus npg A r t i c l e s reconciles observations of both catalytic 6, 9, 24 and noncatalytic 8, 10, 13 roles for OTUB1 while revealing the complexities in accounting for effects of OTUB1 mutations, given the multiple intertwined activities of OTUB1-E2 complexes.
The finding that OTUB1-E2 complexes have dual activity will pave the way to discovery of other roles that these enzyme complexes have in the cell. Although previous studies of OTUB1 inhibition focused on UBC13 (ref. 10), UBCH5A-UBCH5C and UBCH6 form complexes with OTUB1 in vivo 11 and are therefore also likely to have a role in conjunction with OTUB1. Because both E2 inhibition and OTUB1 stimulation depend upon a common OTUB1E2 interface, our find ing could be exploited to identify small molecules that disrupt either function of OTUB1-E2 pairs, through highthroughput screening for small molecules that disrupt E2stimulated cleavage of Lys48 diubiq uitin substrates. Our results reveal another mechanism for regulating ubiquitination and open a new avenue for ubiquitin research.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Coordinates and diffraction data have been deposited in the Protein Data Bank under accession code 4LDT.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Cloning and mutagenesis. Cloning of human OTUB1 was performed as described previously 5 . The genes encoding the E2 enzymes were PCR amplified from a human cDNA library and cloned into a pET vector contain ing an Nterminal His 6 SUMO2 tag (pETSUMO2, Clontech) by Infusion ligasefree cloning. UBCH5B C85S was cloned into the pET32a vector containing the TrxHis tag followed by a TEV protease-cleavage site. All other mutants of OTUB1 and UBCH5B were generated by sitedirected mutagenesis with the QuikChange mutagenesis kit (Stratagene) according to the manufacturer's protocol. The hybrid h/ceOTUB1 was generated as described previously 12 . All hOTUB1 Nterminal deletions were generated with Infusion ligasefree cloning (Clontech).
Protein expression and purification. All proteins were expressed in E. coli Rosetta2(DE3) cells grown in LB medium. Cultures were inoculated with 1% (v/v) overnight saturated cultures and were grown at 37 °C to an OD 600 of 0.8. Proteins were induced at 16 °C overnight by addition of 0.2 mM isopropyl βdthiogalactoside (IPTG). Cells were harvested by centrifugation (8,000g, 15 min) and either lysed immediately or stored at −80 °C for later use.
OTUB1 enzymes and ubiquitin were purified as previously described 5, 12 . Deletions and mutants of human OTUB1 were purified with the same protocol as for the WT proteins. Cell pellets containing expressed E2 proteins were resus pended in lysis buffer (40 mM Na phosphate, pH 8.0, 500 mM NaCl, 25 mM imidazole and 10 mM βmercaptoethanol) supplemented with 0.1 mM PMSF, 5 mM MgCl 2 and DNase I. Cells were lysed with a Microfluidizer (Microfluidics). The lysate was centrifuged to remove cell debris and was subjected to immobi lized metal affinity chromatography (IMAC) with 5mL HisTrap columns (GE Biosciences). The protein was eluted with a linear imidazole gradient. Fractions containing purified protein were pooled and dialyzed overnight at 4 °C against 20 mM Na phosphate, pH 8.0, 300 mM NaCl and 5 mM βmercaptoethanol. TEV or the SENP2 protease 26 was added to the protein pool to cleave off the TrxHis or the HisSUMO2 tag, respectively. Cleaved protein was then subjected to a second round of IMAC, and the flow through containing the cleaved protein was collected. Proteins were further purified by gel filtration on a preparative Superdex 75 column (GE Healthcare), dialyzed into 20 mM HEPES, pH 7.5, 150 mM NaCl and 1 mM DTT, concentrated and stored at −80 °C. Proteins for crystallization and enzyme assays were >98% pure, as visualized on a Coomassie stained SDSPAGE gel.
Purification of OTUB1-Ubal-UBCH5B C85S~U b ternary complex. The oxyesterlinked UBCH5B C85S~U b conjugate was prepared as previously described 27 . Hybrid h/ceOTUB1, Ubal, and UBCH5B C85S~U b were mixed at a 1:2:2 molar ratio and incubated on ice for 45 min. The mixture was then loaded on an analytical Superdex 75 column (GE Healthcare) preequilibrated in 20 mM Tris, pH 7.6, 100 mM NaCl and 2 mM DTT. The OTUB1-Ubal-UBCH5B C85S~U b ternary complex eluted as a single peak and was concentrated to 12 mg/ml and stored at −80 °C.
Crystallization. Crystals of the hybrid h/ceOTUB1-Ubal-UBCH5B C85S~U b complex were grown at 20 °C from a 1:1 mix of purified complex (12 mg/ml) and well solution containing 100 mM BisTris, pH 6, 200 mM MgCl 2 , 22% PEG 3350. Crystals appeared in ~2-3 d and were cryoprotected by well solution with added 10% ethylene glycol and then flash frozen in liquid nitrogen.
Data collection and structure determination. An initial structure of the h/ceOTUB1-Ubal-UBCH5B C85S~U b ternary complex was determined with a 2.5Å diffraction data set collected with an inhouse Rigaku FRE rotating anode Xray generator and a Rigaku Saturn 944+ CCD detector under standard cryogenic conditions and subsequently processed with HKL2000 (ref. 28) . The structure of the ternary complex was determined by molecular replacement with PHASER 29 . The h/ceOTUB1-Ubal complex (PDB 4DHZ 12 ), UBCH5B (PDB 2ESK 30 ) and ubiquitin (PDB 1UBQ 31 ) were used as search models. The model was further refined with successive rounds of realspace refinement in COOT 32 and reciprocalspace refinement with REFMAC in CCP4 (refs. 33, 34) . The 2.5Å structure was refined to an R and R free of 25.36% and 32.43%, respectively.
The initial structure was refined with REFMAC 33,34 against a 1.9Å data set collected at GM/CACAT beamline 23IDD/B at the Advanced Photon Source under standard cryogenic conditions and processed with HKL2000 (ref. 28) . The model was further refined with successive rounds of realspace refinement in COOT 32 and reciprocalspace refinement with REFMAC 33, 34 and PHENIX 35 . The final 1.9Å structure has an R and R free of 19.2% and 22.4%, respectively, with 98% of residues occupying the preferred region of the Ramachandran plot and no Ramachandran outliers. The final structure contains all 76 residues of both ubiquitins, all 148 residues of UBCH5B, and residues 19-251 and 254-275 of h/ceOTUB1. Proteinprotein interaction surfaces were analyzed with the PISA server at EBI (http://www.pdbe.org/PISA/) and manually inspected with COOT and PyMOL (http://www.pymol.org/). Figures were generated with PyMOL.
Assays of OTUB1 isopeptidase activity. FRETbased assays of OTUB1 cleavage of Lys48 diubiquitin were performed at 30 °C in buffer containing 20 mM HEPES, pH 7.5, 100 mM NaCl, 5 mM DTT, 0.01% BSA and 400 nM of Lys48 diubiquitin internally quenched fluorescent (IQF) substrate no. 5 (LifeSensors). Reactions were initiated by addition of the specified amounts of OTUB1. TAMRA fluores cence (ex. 544 nm; em. 590 nm) was monitored with a POLARStar Omega plate reader (BMG LABTECH). The initial rate of Lys48 diubiquitin cleavage was cal culated with the slope of the linear part of the fluorescent curves. For Figures 1b  and 4c , nonlinear regression fitting in GraphPad Prism (GraphPad Software) was used to analyze the data and fit the 50% stimulation/inhibition concentrations.
Assays of OTUB1 cleavage of ubiquitinAMC were performed at 30 °C in buffer containing 20 mM HEPES, pH 7.5, 100 mM NaCl, 5 mM DTT, 0.01% BSA and 10 µM of ubiquitinAMC (Boston Biochem). Reactions were initiated by the addition of 5 µM OTUB1 and carried out in the presence or absence of 10 µM UBCH5B. AMC fluorescence (ex. 380 nm; em. 460 nm) was monitored with a POLARStar Omega plate reader (BMG LABTECH).
Gelbased assays for UBCH5B stimulation of OTUB1 isopeptidase activity were performed at 37 °C in reaction buffer containing 20 mM HEPES, pH 7.5, 100 mM NaCl and 5 mM DTT. 500 nM hOTUB1 was mixed with 15 µM unlabeled Lys48 diubiquitin in the presence or absence of 25 µM UBCH5B. Reactions were initiated by the addition of the OTUB1 enzyme. Aliquots were removed at the specified time points and the reactions quenched by the addition of denaturing SDSPAGE loading dye containing βmercaptoethanol. Samples were analyzed by gel electrophoresis on 4-12% polyacrylamide BisTris Criterion XT gels (BioRad). Gels were stained with Coomassie brilliant blue.
Steady-state kinetic assays of OTUB1 deubiquitinating activity. Steadystate enzyme kinetic assays were performed at 37 °C in a reaction buffer containing 20 mM HEPES, pH 7.5, 100 mM NaCl and 5 mM DTT. Human OTUB1 (30 nM) was mixed with specified amounts of Lys48linked diubiquitin in the presence or absence of 10 µM UBCH5B. Aliquots of the reaction mixtures were removed at specified time points, quenched by the addition of denaturing SDSPAGE load ing dye containing βmercaptoethanol, and analyzed by SDSPAGE followed by staining with SYPRO Ruby protein stain (Life Technologies). The concentration of the ubiquitin product band for each time point was quantified by densitometry with ImageJ software 36 . Reaction velocities were then determined for each Lys48 diubiquitin concentration and fit to the Michaelis-Menten equation with the GraphPad Prism software .
Assays of E2 charging in cultured cells. HeLa or U2OS cells were grown in
Dulbecco's modified Eagle's medium supplemented with 10% FBS and 10 mM HEPES. Cells were cultured at 37 °C in a humidified incubator with 5% CO 2 . Lysates were prepared in lowpH lysis buffer (50 mM MES, pH 4.5, 150 mM NaCl, 0.2% Nonidet P40 and protease inhibitors) and in the absence of reducing agent as previously described 15 and immediately loaded onto an SDSPAGE gel with or without added βmercaptoethanol. E2 enzymes were visualized by western blotting with antibodies (1:1,000 dilution) that react with all UBCH5 isoforms (UBCH5 polyclonal Ab, cat. no. A615, Boston Biochem) or with UBC13 (UBC13 monoclonal Ab, cat. no. 371100, Life Technologies). 
